ADVDRUG Logo w Taqgline 500px

Click below to see the agendas, presenters and abstracts from past forums:

 

PROGRAM AGENDAThursday, November 30, 2017 
8:30  Networking Breakfast and Registration
9:00  Welcome Address and Opening RemarksShelley Amster, Founder, ShelleyCO, LLC & CEO, InsideOutBio
9:15Opening Keynote – Minimizing CMC Risk to Maximize Probability of Success

Anthony A. McKinney, Founder, President & CEO, Ethismos, Founder and Chief Development Officer, Neurovance, Inc.
Successes of Implementing Innovative Technologies
10:00  Success in the Virtual Pharma World - The Impact of Your CDMOSimon McGurk,  Ph.D., Executive Director, TESARO, Inc.
10:30  Networking Refreshment Break    
11:00   Overcoming Regulatory Barriers To Implementing Innovative TechnologiesPrabu Nambiar, Ph.D., Principal, Syner-G Pharma CMC Consulting, LLC
11:30  Bringing Innovative Technologies and New Approaches to the ‘CDMO World’ Colin Minchom , Ph.D.,  FRPharmS., (previously) Senior Director Pharmaceutical Sciences, Shire Pharmaceuticals; Founder & Principal CMC Consultant, Cordack Consulting
Panelist:
Matt Bio, CEO, SnapDragon Chemistry
Roger Frechette, Ph.D., Principal, New England PharmAssociates, LLC
12:00   Networking Luncheon Sponsored by:
The Newest and Hottest Implemented Technologies
1:00Keynote: A chairman’s view on innovationJames A. Geraghty, Chairman Juniper Pharmaceuticals (tentative)
1:30  Novel Drug Delivery: Challenges and How to Increase Your SuccessManuel Sanchez-Felix, Ph.D., Senior Fellow, Novel Delivery Technologies, Novartis Institute for Biomedical Research
2:00   Virtual Laboratory
Interconnecting your CMOs and CROs
Kevin J. Bittorf, VP CMC and BD, Trek Therapeutics.
2:30  Refreshment Break ‘Afternoon Tea’ 
2:50Organizational Excellence: Innovation Fits All SizesPadma Narayan, Ph.D., Director, Formulation Development, Tech Ops Development, SAGE Therapeutics
3:20Implementing the Impossible:
Panel Discussion and Forum
Moderator:
Don Dickison, Vice President, Business Development Juniper Pharma Services
Distinguished Panel:
Konstantin Tsinman, Chief Scientific Officer, Pion Inc.  
Alok Tayi, Ph.D., CEO, TetraScience,
Carl Beckett, VP, BD, Covaris
4:00  Closing Fireside Keynote Discussion – Breaking Down Barriers to Adoption of New Technology
Moderator: Manuel Sanchez-Felix, Ph.D.
Featuring:
Ibis Sánchez-Serrano, MBA, President & CEO of "The Core Model Corporation" (C.M.C.)  
5:00Closing Remarks   
5:15-8:00  Cocktail HourSponsored by:


PROGRAM AGENDAThursday, June 14, 2018
8:30 AMNetworking Breakfast and Registration
9:00 AMShelley Amster, Founder, ShelleyCO, LLC & CEO, InsideOutBioWelcome Address and Opening Remarks by Organizers
9:15 AMOpening Keynote:
Alok Tayi, Ph.D.,
CEO, TetraScience
Named top 40 CEOs Under 40
‘Digital BioTech’
10:00 AMLara Park-Menning,
Co-founder and COO of Nucleo Life Sciences.
Giving Failed Drugs a Fresh Start and a New Direction
10:30 AMNetworking Refreshment Break
11:00 AMSimon McGurk, Ph.D.,
Executive Director, TESARO, Inc
Success in the Virtual Pharma World - The Impact of Your CDMO
11:30 AMKevin J. Bittorf, Vice President: CMC, In-Licensing, and Co-Founder, Trek Therapeutics
Alok Tayi, PhD., CEO, TetraScience
Introducing, Incorporating and Integrating Novel Technologies
Panel Discussion
12:00  NoonLunch
12:50 PMAfternoon Keynote:
Wei Tao, Ph.D.
Board Director & Chair, Bio/Genomics Committee, Life Science Angels
Early Stage Biopharma Investment in the Era of AI and Big Data
1:20 PMMagali Hickey, Ph.D.,
Senior Director, Pharmaceutical Chemistry and Formulation Development, Alkermes
Risk, Reward Assessment of Novel Formulation Approaches: When, Why and Why Not?
1:50 PMRichard Kenley, Ph.D.,
Founder, PLADD Consulting, LLC
Development, Testing, and Manufacturing of an Anti-Parasitic Topical Drug Product - Case Study
2:05 PMEyal S. Ron, Ph.D.,
Principal, MADASH & Managing Partner, Sensei Ventures
The Human Side of Drug Development - Building RelationsCase Studies
2:20 PMRay Sison, Ph.D.,
Principal Consultant, Xcell Strategic Consulting
Case Study:
Everything Old is New Again – Recycling, Repurposing and Extrapolating Existing Technologies For Use in Pharma
2:35 PMRichard Kenley, Ph.D., Founder, PLADD Consulting, LLC
Eyal S. Ron, PhD., Principal, MADASH & Managing Partner, Sensei Ventures
Ray Sison, Principal Consultant , Xcell Strategic Consulting
Consultants are the Glue to a Successful ROI
Panel Discussion
Wine Tasting “SFO Wine School”
Networking Break
3:30 PMKarthik Nagapudi, Ph.D. ,
Senior Scientist, Genentech
Drug Product Development in the Era of Complex Molecules and Accelerated Development Timelines
4:00 PMClosing Fireside Keynote Discussion
Featuring Our Faculty and All AttendeesThe Changed Paradigm of Drug Development
5:00 PMClosing Remarks   
5:30 PM - 8:00 PMCocktail Hour: Sponsored by Juniper Sponsored by: